Evidence map›Paper›PMID 31605506›Full record

ArticleFEBS open bio2019

NGF protects neuroblastoma cells against β-amyloid-induced apoptosis via the Nrf2/HO-1 pathway.

Rui Su, Wei Su, Qian Jiao

RetractedErratum issuedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Rui SuDepartment of Neurosurgery, Luoyang Central Hospital Affiliated to Zhengzhou University, China.ORCID 0000-0002-2642-1474
Wei SuDepartment of Intensive Care Unit, Sir Run Run Shaw Hospital Affiliated by Zhejiang University School of Medicine, Hangzhou, China.
Qian JiaoDepartment of Anesthesia Surgery, Sanmenxia Central Hospital, China.
Luoyang Central Hospital Affiliated to Zhengzhou University · CNSir Run Run Shaw Hospital · CNXian Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the main neurotrophic factors, nerve growth factor (NGF) participates in various processes related to viability, plasticity, and neuronal growth. NGF is known to protect against cell death and toxicity triggered by β-amyloid (Aβ), but the underlying mechanism remains unclear. Here, we investigated this process in SKNSH neuroblastoma, in which NGF reduced cell death induced by Aβ25-35. Furthermore, NGF suppressed the production of reactive oxygen species (ROS) and promoted antioxidant function via Aβ25-35. Additionally, we demonstrated that NGF impaired the activation of the JNK/c-Jun signaling pathway and significantly increased Nrf2 nuclear translocation and HO-1 expression. Nrf2 elimination abolished the protective effect of NGF-1 on Aβ25-35-induced ROS generation, apoptosis, and activation of the JNK/c-Jun pathway. The results of our study indicate that NGF protects neuroblastoma against injury triggered by Aβ25-35 via suppression of ROS-JNK/c-Jun pathway stimulation through the Nrf2/HO-1 pathway.

Indexed as

Amyloid beta-PeptidesAnimalsAntioxidantsApoptosisCell DeathCell Line, TumorCell SurvivalHeme Oxygenase-1HumansMiceNerve Growth FactorNeuroblastomaNeuroprotective AgentsNF-E2-Related Factor 2Oxidative StressPeptide FragmentsAmyloid beta-Peptidesamyloid beta-protein (25-35)AntioxidantsHeme Oxygenase-1Nerve Growth FactorNeuroprotective AgentsNF-E2-Related Factor 2Peptide FragmentsReactive Oxygen SpeciesapoptosisJNK/c-JunNGFNrf2β-amyloid

Identifiers

PMID31605506
PMCPMC6886293
OpenAlexW2979401593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.